Browse Items · NEOMED Bibliography Database

Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.

PURPOSE: The EORTC QLQ-C30 and the Brief Pain Inventory (BPI) are validated tools for measuring quality of life (QOL) and the impact of pain in patients with advanced cancer. Interpretation of these instrument scores can be challenging and it is…

Tags: *Bone metastases, *Brief pain inventory, *EORTC QLQ-C30, *Minimal Clinically Important Difference, *Minimal clinically important differences, *Radiation, 2018, 80 and over, Adolescence, Adolescent, Adult, Aged, Babington Scott, Bone Metastases – Radiotherapy, BONE metastasis, BONE metastasis – Treatment, Bone Neoplasms/*complications/radiotherapy/secondary, Brief pain inventory, Brundage Michael, Cancer Patients, CANCER radiotherapy, Chow Edward, Clinical Assessment Tools, Demas William F, Ding Keyue, Female, Funding Source, Haas Rick, Hartsell William F, Hoskin Peter, Human, Humans, Instrument Scaling, LONGITUDINAL method, Male, Meyer Ralph M, Middle Age, Middle Aged, Nabid Abdenour, Pain Management, Pain/*diagnosis, Prospective Studies, Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, Quality of Life/*psychology, Questionnaires, Raman Srinivas, RANDOMIZED controlled trials, Re-Irradiation/*adverse effects, Reoperation, Repeat Procedures, RESEARCH funding, Roos Daniel, SCALING (Social sciences), Secondary Analysis, Surveys and Questionnaires, van der Linden Yvette M, Wiggenraad Ruud, Wilson Carolyn F, Wong Rebecca K S, Wu Jackson S Y, Young Adult, Zhu Liting

Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

OBJECTIVES: The goals of treating recurrent platinum-resistant ovarian cancer are palliative, aimed at reducing symptoms and improving progression free survival. A prospective trial was conducted to determine the prevalence and severity of symptoms,…

A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne.

INTRODUCTION: Acne has a significant negative impact on quality of life (QoL): lack of self-confidence, depressive symptoms and suicidal thoughts. The objective was to assess the impact of an initial and continued therapy in severe acne patients…

Browse Items (3 total)

Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.

Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne.